PT817858E - Preparacoes fotoprotectoras que compreendem derivados de triazina - Google Patents

Preparacoes fotoprotectoras que compreendem derivados de triazina

Info

Publication number
PT817858E
PT817858E PT96907398T PT96907398T PT817858E PT 817858 E PT817858 E PT 817858E PT 96907398 T PT96907398 T PT 96907398T PT 96907398 T PT96907398 T PT 96907398T PT 817858 E PT817858 E PT 817858E
Authority
PT
Portugal
Prior art keywords
vectors
relates
present
understand
derivatives
Prior art date
Application number
PT96907398T
Other languages
English (en)
Inventor
Robert Michael Saller
Walter H Gunzburg
David Winder
Original Assignee
Gsf Forschungszentrum Umwelt U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt U filed Critical Gsf Forschungszentrum Umwelt U
Publication of PT817858E publication Critical patent/PT817858E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PT96907398T 1995-03-09 1996-03-08 Preparacoes fotoprotectoras que compreendem derivados de triazina PT817858E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK24395 1995-03-09

Publications (1)

Publication Number Publication Date
PT817858E true PT817858E (pt) 2003-09-30

Family

ID=8091353

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96907398T PT817858E (pt) 1995-03-09 1996-03-08 Preparacoes fotoprotectoras que compreendem derivados de triazina

Country Status (10)

Country Link
US (1) US7022319B1 (pt)
EP (1) EP0817858B1 (pt)
JP (1) JP3908274B2 (pt)
AT (1) ATE238427T1 (pt)
AU (1) AU5103996A (pt)
DE (1) DE69627644T2 (pt)
DK (1) DK0817858T3 (pt)
ES (1) ES2198479T3 (pt)
PT (1) PT817858E (pt)
WO (1) WO1996028563A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200517T1 (de) * 1994-09-02 2001-04-15 Gsf Forschungszentrum Umwelt Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
GB9621680D0 (en) * 1996-10-17 1996-12-11 Oxford Biomedica Ltd Lentiviral vectors
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
GB9720465D0 (en) * 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
ATE298371T1 (de) 1997-09-24 2005-07-15 Univ California Nicht-primaten lentivirale vektoren und verpackungssysteme
GB2344592B (en) * 1997-09-25 2002-09-11 Oxford Biomedica Ltd Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
WO1999035280A1 (en) 1998-01-06 1999-07-15 Bavarian Nordic Research Institute A/S Reconstituting retroviral vector (recon vector) for targeted gene expression
GB9817693D0 (en) * 1998-08-14 1998-10-07 Bridgehead Technologies Limite Virally-mediated targeting of drugs and genetic material
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
GB9906615D0 (en) * 1999-03-22 1999-05-19 Oxford Biomedica Ltd Vector
CA2690815A1 (en) * 2007-06-12 2008-12-18 Case Western Reserve University Targeted cell death
JP2012533521A (ja) * 2008-07-17 2012-12-27 ニュートリペップ・ピーティーワイ・リミテッド 治療剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000194A1 (en) * 1987-07-06 1989-01-12 Louisiana State University Agricultural And Mechan Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides
US4822608A (en) 1987-09-14 1989-04-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
CA1335798C (en) 1988-05-17 1995-06-06 Sloan Kettering Institute For Cancer Research Retroviral vector
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
GB8919607D0 (en) 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1991008753A1 (en) * 1989-12-07 1991-06-27 Gesellschaft Für Strahlen- Und Umweltforschung Mbh (Gsf) Method and composition for the treatment of mammalian hiv infection
US6027722A (en) * 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
ATE188125T1 (de) * 1991-10-25 2000-01-15 Sidney Kimmel Cancer Ct Lymphokine gentherapie bei krebs in kombination mit tumorantigenen
US5302706A (en) 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
AU7177494A (en) 1993-06-25 1995-01-17 Board Of Regents, The University Of Texas System Pore-forming and superantigen encoding toxin cassettes for gene therapy
WO1995001095A1 (en) * 1993-06-30 1995-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Transformed eukaryotic cells, and transposon-based transformation vectors
JP3822232B2 (ja) 1993-08-30 2006-09-13 ベイラー・カレッジ・オブ・メディシン 老化細胞由来ｄｎａ合成阻害因子
WO1995013375A1 (en) 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
ATE200517T1 (de) * 1994-09-02 2001-04-15 Gsf Forschungszentrum Umwelt Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
EP1162273A1 (en) 1995-03-09 2001-12-12 Austrian Nordic Biotherapeutics AG Recombinant DNA vectors for gene therapy
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
CA2222559A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
DE69619683T2 (de) 1995-09-06 2002-09-26 Austrian Nordic Biotherapeutic Expression von heterologen genen in menschlichen brustzellen, einschliesslich menschliche brustkarzionomzellen unter der kontrolle von regulatorischen sequenzen von wap oder mmtv
US5863904A (en) 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21
WO1999020742A2 (en) 1997-10-20 1999-04-29 Universita' Degli Studi Di Padova A packaging cell line producing siv-pseudotyped mlv
WO1999035280A1 (en) 1998-01-06 1999-07-15 Bavarian Nordic Research Institute A/S Reconstituting retroviral vector (recon vector) for targeted gene expression

Also Published As

Publication number Publication date
AU5103996A (en) 1996-10-02
DK0817858T3 (da) 2003-08-11
EP0817858A1 (en) 1998-01-14
ES2198479T3 (es) 2004-02-01
JP3908274B2 (ja) 2007-04-25
ATE238427T1 (de) 2003-05-15
US7022319B1 (en) 2006-04-04
DE69627644D1 (de) 2003-05-28
JPH11503305A (ja) 1999-03-26
WO1996028563A1 (en) 1996-09-19
EP0817858B1 (en) 2003-04-23
DE69627644T2 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
PT817858E (pt) Preparacoes fotoprotectoras que compreendem derivados de triazina
CZ63995A3 (en) Virus vectors and their use in gene therapy
DE69830663D1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
HUP9902310A2 (hu) Komplementer adenovírus-vektorrendszerek és sejtvonalak
DE69326069T2 (de) Zusammensetzungen die die hiv replikation inhibieren
ES2053413T3 (es) Peptidos que inducen anticuerpos que neutralizan aislados de vih-1 geneticamente divergentes.
ATE260980T1 (de) Die erzielung hoher titer des rekombinanten aav- vektors
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
MX336118B (es) Expresion hibrida y en tandem de proteinas de neisseria.
RU95115239A (ru) Аналог эритропоэтина
NZ320889A (en) A p35 protein which binds to and inhibits chemokines
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
DE68927379D1 (de) Plättchen blockierende peptide
BR0312889A (pt) Polipeptìdeo t20 peguilado
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
HUP9802587A2 (hu) Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek
ATE296314T1 (de) Peptide des env-gens vom katze immunschwäche- virus und deren verwendung
ATE240349T1 (de) Peptide zur inhibierung von hpv e6-proteinen
HUP9900011A2 (hu) A GAX protein alkalmazása rák kezelésére
MX2023006869A (es) Proteinas de union condicionalmente biespecificas.
NO20022468L (no) Genterapi av HIV-positive pasienter ved ekspresjon av membranforankrede GP41-peptider
SE9700301D0 (sv) New compound
ATE277186T1 (de) Zusammensetzung von transdominanten varianten von virus- proteinen zur antiviralen wirkung
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
WO2000078939A3 (de) Vektoren zur gentherapeutischen tumorbehandlung